Lantern Pharma Inc. SEC filings LTRN
Lantern Pharma Inc. has 262 filings in SEC EDGAR's recent list, going back to Jan 14, 2019. Its latest annual report, Form ARS, was filed on Oct 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Oct 21, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Oct 19, 2026 | Oct 19, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 8, 2026 | Oct 8, 2026 |
| 8-K |
Current report
Listing notice
|
Oct 1, 2026 | Sep 25, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 30, 2026 | Sep 28, 2026 |
| 424B5 | Prospectus supplement | Sep 30, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 24, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 23, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 3, 2026 | Aug 3, 2026 |
| EFFECT | Filing | Jun 18, 2026 | — |
| S-1 | Registration statement | Jun 12, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 2, 2026 | Jun 1, 2026 |
| D | Filing | May 21, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 15, 2026 | May 15, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
May 14, 2026 | May 12, 2026 |
| 424B5 | Prospectus supplement | May 14, 2026 | — |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 10, 2026 | Apr 9, 2026 |
| 424B5 | Prospectus supplement | Mar 30, 2026 | — |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 30, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 23, 2026 | Jan 22, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Sep 23, 2025 | Sep 19, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| ARS | Annual report to shareholders | Aug 11, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Aug 8, 2025 | Aug 8, 2025 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Jul 29, 2025 | Jul 24, 2025 |
| PRE 14A | Preliminary proxy statement | Jul 28, 2025 | Jul 28, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 3, 2025 | Jul 3, 2025 |
| 424B5 | Prospectus supplement | Jul 3, 2025 | — |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2025 | May 15, 2025 |
| 10-K/A | Amended annual report | Apr 30, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 10, 2025 | Jan 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 8, 2024 | Nov 7, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2024 | Jun 13, 2024 |
| EFFECT | Filing | Jun 10, 2024 | — |
| CORRESP | Letter to the SEC | Jun 6, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 24, 2024 | May 23, 2024 |
| S-8 | Employee stock plan registration | May 24, 2024 | — |
| S-3 | Shelf registration | May 24, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | May 3, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 29, 2024 | Apr 29, 2024 |
| 10-K | Annual report | Mar 18, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 18, 2024 | Mar 18, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 29, 2023 | Dec 29, 2023 |
| 8-K |
Current report
Material agreement
|
Nov 24, 2023 | Nov 21, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Other events
|
Oct 20, 2023 | Oct 17, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 9, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2023 | Jun 16, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2023 | May 9, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| ARS | Annual report to shareholders | May 5, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Apr 28, 2023 | Apr 27, 2023 |
| 10-K | Annual report | Mar 20, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 20, 2023 | Mar 20, 2023 |
| 8-K |
Current report
Officer or director change
|
Jan 18, 2023 | Jan 12, 2023 |
| 10-Q | Quarterly report | Nov 7, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 7, 2022 | Nov 7, 2022 |
| 10-Q | Quarterly report | Aug 8, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2022 | Jun 8, 2022 |
| DEFA14A | Additional proxy material | May 3, 2022 | — |
| 10-Q | Quarterly report | May 3, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 3, 2022 | May 3, 2022 |
| DEF 14A | Proxy statement | Apr 27, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 26, 2022 | Apr 20, 2022 |
| 8-K |
Current report
Other events
|
Apr 25, 2022 | Apr 25, 2022 |
| 8-K |
Current report
Other events
|
Mar 22, 2022 | Mar 22, 2022 |
| 10-K | Annual report | Mar 10, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 10, 2022 | Mar 10, 2022 |
| 8-K |
Current report
Other events
|
Jan 24, 2022 | Jan 24, 2022 |
| 8-K |
Current report
Other events
|
Nov 22, 2021 | Nov 22, 2021 |
| 10-Q | Quarterly report | Nov 1, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 1, 2021 | Nov 1, 2021 |
| 10-Q | Quarterly report | Jul 29, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 29, 2021 | Jul 29, 2021 |
| EFFECT | Filing | Jul 12, 2021 | — |
| CORRESP | Letter to the SEC | Jul 8, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 7, 2021 | — |
| S-3 | Shelf registration | Jul 2, 2021 | — |
| 8-K |
Current report
Shareholder vote results
|
May 25, 2021 | May 19, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 3, 2021 | May 3, 2021 |
| 10-Q | Quarterly report | May 3, 2021 | Mar 31, 2021 |
| DEFA14A | Additional proxy material | Apr 9, 2021 | — |
| DEF 14A | Proxy statement | Apr 9, 2021 | May 19, 2021 |
| 10-K | Annual report | Mar 10, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 10, 2021 | Mar 10, 2021 |
| 424B4 | Prospectus | Jan 15, 2021 | — |
| S-1MEF | Registration statement | Jan 15, 2021 | — |
| EFFECT | Filing | Jan 14, 2021 | — |
| CORRESP | Letter to the SEC | Jan 11, 2021 | — |
| FWP | Free writing prospectus | Jan 11, 2021 | — |
| CORRESP | Letter to the SEC | Jan 8, 2021 | — |
| S-1 | Registration statement | Jan 8, 2021 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jan 6, 2021 | Dec 30, 2020 |
| UPLOAD | Letter from the SEC | Dec 21, 2020 | — |
| DRS | Filing | Dec 16, 2020 | — |
| DRSLTR | Filing | Dec 15, 2020 | — |
| 10-Q | Quarterly report | Oct 29, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 29, 2020 | Oct 29, 2020 |
| 8-K |
Current report
Officer or director change
|
Aug 21, 2020 | Aug 19, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 30, 2020 | Jul 30, 2020 |
| 10-Q | Quarterly report | Jul 30, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Material agreement
|
Jul 16, 2020 | Jul 10, 2020 |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change, Other events
|
Jun 17, 2020 | Jun 11, 2020 |
| SEC STAFF LETTER | Filing | Jun 16, 2020 | — |
| 424B4 | Prospectus | Jun 12, 2020 | — |
| S-1MEF | Registration statement | Jun 12, 2020 | — |
| EFFECT | Filing | Jun 10, 2020 | — |
| CERT | 8a cert | Jun 8, 2020 | — |
| CORRESP | Letter to the SEC | Jun 8, 2020 | — |
| CORRESP | Letter to the SEC | Jun 8, 2020 | — |
| 8-A12B | For registration of certain classes | Jun 8, 2020 | — |
| S-1/A | Amended registration statement | Jun 8, 2020 | — |
| CORRESP | Letter to the SEC | Jun 2, 2020 | — |
| UPLOAD | Letter from the SEC | May 29, 2020 | — |
| CORRESP | Letter to the SEC | May 22, 2020 | — |
| UPLOAD | Letter from the SEC | May 22, 2020 | — |
| FWP | Free writing prospectus | May 19, 2020 | — |
| S-1/A | Amended registration statement | May 19, 2020 | — |
| CORRESP | Letter to the SEC | May 12, 2020 | — |
| S-1/A | Amended registration statement | May 12, 2020 | — |
| UPLOAD | Letter from the SEC | May 1, 2020 | — |
| CORRESP | Letter to the SEC | Apr 16, 2020 | — |
| S-1 | Registration statement | Apr 16, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 21, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 21, 2020 | — |
| DRSLTR | Filing | Jan 24, 2020 | — |
| DRS | Filing | Jan 24, 2020 | — |
| D | Filing | Mar 18, 2019 | — |
| D | Filing | Jan 14, 2019 | — |
Showing 150 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LTRN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- TX
- Headquarters
- Dallas, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1763950
- Former names
- Lantern Pharma (until Jan 14, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.